Virtual integrated care platform Recuro Health has announced the closing of a $47 million Series B financing round. ARCH Venture Partners, Flippen Group, GPG Ventures, 4D Capital and other investors participated in the raising. What they do Recuro Health’s digital medical home offering includes healthcare services for patients, including behavioral health care, virtual primary and urgent care, genomic testing and in-home laboratory testing. The company works with employers to provide customizable digital health offerings for their employees and with health plans and providers to connect their members and patients with the right care teams. Recuro will use the funding to grow and develop its digital medical home care model, which includes virtual primary care and behavioral health offerings. “The continued support of our investors is a clear sign of their confidence in our mission,” Michael Gorton, founder of Recuro Health, said in a statement. “At Recuro, we have an exceptional team dedicated to advancing healthcare by making healthcare more proactive and personalized, resulting in improved outcomes, better patient engagement and lower costs. We are committed to building on the success of our company’s continued growth and expansion. Our digital medical home and the next generation of digital We will continue to grow care services. Market Snapshot In 2021, the company received $15 million in Series A funding. That same year, the company acquired MyLifeIQ, an epigenetics platform, and SupDoc, an AI-enabled virtual health platform. Last year, Recuro, which connects patients with physicians and behavioral health specialists Acquires Virtual Health Provider Welvia Announces Acquisition of Competitive Health Digital Health Company Offers Employer Products to Reduce Costs, Maximize Employer ROI, and Promote Engagement Provides more detail in “Views from Above: Existential Crisis or Inflection Point Opportunity?” An Industry Maverick View.” Tuesday, April 18, 3pm – 4pm CT in South Building, Level 1, Room S100 B.